A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy
Cancers - Switzerland
doi 10.3390/cancers12030745
Full Text
Open PDFAbstract
Available in full text
Date
March 21, 2020
Authors
Publisher
MDPI AG